Topic Summary
Healthed brings together four leading experts in infectious disease, cardiology, geriatrics and diabetes for a lively, authoritative, cross disciplinary discussion.
For medical practitioners, it is critical to monitor cardiovascular function in patients with RSV infection, especially those with known heart disease or at high risk of cardiovascular complications. Management should ideally be multidisciplinary, involving both Cardiologists and Pulmonologists to address the complex interplay between respiratory and cardiovascular systems during an RSV infection.
This high-powered panel will provide many useful clinical insights that GPs will find invaluable as they come to understand the significance of RSV and the potential of the new vaccines to improve health outcomes.
Learning Objectives
- Examine the impact of RSV infection on cardiovascular health, particularly those with existing heart disease or at high cardiovascular risk
- Implement a collaborative approach to manage RSV-infected patients, fostering effective strategies for their comprehensive care and optimal outcomes
- Review RSV vaccine impact and analyse the clinical impact of new RSV vaccines on health outcomes
CPD and Accreditation
This activity is accredited with the RACGP and ACRRM for 1 hour in the Educational Activities (EA) category.
Disclosure Statement
The content presented has been independently developed without intervention from GSK. The views and opinions expressed in the presentations are solely those of the presenters and should not be attributed to any organisation with which the presenters are employed or affiliated, and are not necessarily the views of GSK.
Proudly supported by an independent educational grant from GSK. August 2024
